|
Karmelsonix Limited - Company Profile Snapshot
| Company Profile: |
Karmelsonix Limited |
| Ticker: |
KSX |
| Exchanges: |
SYD |
| 2009 Sales: |
225,430 |
| Major Industry: |
Miscellaneous |
| Sub Industry: |
Miscellaneous Companies |
| Country: |
AUSTRALIA |
| Employees: |
2 |
Business Description
Karmelsonix Limited Formerly known as Salus Technologies Limited. The Group's principal activities are researching, developing and commercialising medical devices. Its products primarily include non-invasive clinical solutions for patients with cardio-pulmonary disorders such as asthma, congestive heart failure (CHF), acute respiratory distress syndrome (ARDS), obstructive sleep apnea (OSA), emphysema, and chronic obstructive pulmonary disease (COPD). The Group acquired PulmoSonix Ltd and Karmel Sonix (Israel) Ltd in 21 November 2006 and disposed of its interest in Advanced Wound Care Pty Ltd in 14 December 2006. It operates in Australia and Israel.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
